All In MedTech

Device Trial Radar · NCT00446732

The Use of the UroShield Device in Patients With Indwelling Urinary Catheters

Catheter Associated Urinary Tract Infections

Last checked: Nov 20, 2026Latest source record: Mar 25, 2009 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknownPivotal-lookingRandomized with 200 participants. This is a heuristic, not a regulatory label.

Status

Status unknown

Enrollment

200

Planned (sponsor's estimate)

Start

Mar 2007

Primary completion

Apr 2009

Study completion Jun 2009

Sponsor

Lead sponsor
NanovibronixNot on our public-company list
Sponsor type
Industry
Collaborators
Shaare Zedek Medical Center
First posted
Mar 13, 2007

More device trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2 / Phase 3
Allocation
Randomized
Model
Single group
Masking
None
Primary purpose
Prevention
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

According to the Israeli Ministry of Health requirement, this study was designed to evaluate the efficacy of the UroShield system is patients that require urinary catheterization. This was designed to compare standard treatment (urinary catheter alone) with the UroShield treatment in occurrence of catheter associated Urinary Tract infection, pain, discomfort, Biofilm prevention and trauma.

Conditions

  • Urinary Tract Infection

Interventions

  • UroSshieldDevice

    Attachment of the UroShield device to the external part of the urinary catheter

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. primary end pointsTime frame: up to 14 days

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Shaare Zedek Medical Center

    Jerusalem, Israel · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.